ESC 365 - Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition

ESC Premium Access

Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition

Session: Current pharmacological treatments for pulmonary hypertension

Topic: Diagnostic Methods

Speaker: Doctor S. Lee (Seoul, KR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Soyoung Lee

Seoul St. Marys Hospital, Seoul (Korea (Republic of))

0 follower

8 more presentations in this session

Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL).

Speaker: Doctor M. Waligora (Krakow, PL)

Combined ARNI and SGLT2i impacts on peak tricuspid regurgitant velocity and echocardiographic probability of pulmonary hypertension

Speaker: Doctor M. Stracqualursi (Milan, IT)

The safety and efficacy of treprostinil for the treatment of pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr H. Khasawneh (Irbid, JO)

Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension : insights from a single-centre study

Speaker: Doctor H. Tokgoz (Istanbul, TR)

Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial

Speaker: Doctor A. Pius (New Delhi, IN)

Access the full session

Current pharmacological treatments for pulmonary hypertension

Speakers: Doctor S. Lee, Doctor M. Waligora, Doctor M. Stracqualursi, Mr H. Khasawneh, Doctor H. Tokgoz...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources